Relmada Therapeutics (RLMD) is a clinical-stage pharma company with no commercialized products and a $141 million market cap. ・RLMD has shown strong technical momentum, gaining 440% since August.

SpiceJet rose sharply as massive IndiGo flight disruptions boosted sentiment for the stock. IndiGo’s operational troubles, ...

Investors in Solana have endured a challenging November. The blockchain platform, once a market darling, has shed over 57% of ...

A smart manufacturing strategy rarely starts on a factory floor. It starts with a decision about what you should own and what you should rent ...

Many investors assume that paying a pro to pick stocks will guarantee better returns than a simple index fund, but reality begs to differ. Studies consistently show that over the long term, most ...

S&P 500's forward 10-year returns are often misrepresented as tightly & negatively correlated with trailing P/E ratios. Read ...

Shares of alternative asset manager Ares Management (NYSE:ARES) jumped 8.5% in the afternoon session after reports revealed ...

Roku shares crashed 90% from their peak, then started climbing back. Is it a buy today or just a cautionary tale?

Why buy Reddit stock. It's a great sign that Reddit's advertising revenue continues to grow at a significantly faster rate ...

The secret is in the 300-year-old language of day trading. Opinions expressed by Entrepreneur contributors are their own.

Walmart has been operating its low-price stores for decades. The company invests in technology to remain competitive in the ...

Shopify's SaaS investments drive revenue growth and AI monetization, but is SHOP stock overvalued? Read our analysis before ...